Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorFREMOND, Marie-Louise
dc.contributor.authorDAVID, Clemence
hal.structure.identifierImmunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
dc.contributor.authorRICHEZ, Christophe
dc.date.accessioned2024-10-16T12:48:46Z
dc.date.available2024-10-16T12:48:46Z
dc.date.issued2024-09
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/202539
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.subject.enAutoimmune diseases
dc.subject.enInflammation
dc.subject.enTherapeutics
dc.title.enAnifrolumab: the new frontier in the treatment of genetic interferonopathies
dc.typeArticle de revueen_US
dc.identifier.doi10.1136/rmdopen-2024-004780en_US
dc.subject.halSciences du Vivant [q-bio]/Immunologieen_US
dc.identifier.pubmed39313304en_US
bordeaux.journalRMD Openen_US
bordeaux.volume10en_US
bordeaux.hal.laboratoriesImmunoConcEpT - UMR 5164en_US
bordeaux.issue3en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-04739859
hal.version1
hal.date.transferred2024-10-16T12:48:49Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccCC BY-NCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=RMD%20Open&rft.date=2024-09&rft.volume=10&rft.issue=3&rft.au=FREMOND,%20Marie-Louise&DAVID,%20Clemence&RICHEZ,%20Christophe&rft.genre=article


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record